The Laboratory Medicine and the care of patients infected by the Ebola virus. Experience in a reference hospital of Madrid, Spain

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 12, 2015, Pages 1903-1910

  Fernandez Puntero, Belen ^a   Gomez Rioja, Ruben ^a   Alcaide, Maria Jose ^a   Oliver, Paloma ^a   Fernandez Calle, Pilar ^a   Iturzaeta, Jose Manuel ^a   Buno, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Ebola virus; personal protective equipment; point of care testing; safety

Indexed keywords

BLOOD GAS ANALYZER; CHEMICAL ANALYZER; DISINFECTION; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; FOLLOW UP; GOOD LABORATORY PRACTICE; HEMATOLOGY ANALYZER; HOSPITAL LABORATORY; HOSPITAL WASTE; HUMAN; ION ANALYZER; LABORATORY PERSONNEL; LABORATORY TEST; LETHALITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; ORGANIZATIONAL STRUCTURE; PATIENT CARE; PHYSICIAN; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; SPAIN; STAFF TRAINING; TOTAL QUALITY MANAGEMENT; VIRAL CONTAMINATION; VIREMIA; WASTE DISPOSAL; WORLD HEALTH ORGANIZATION; HEALTH CARE DELIVERY; HEMORRHAGIC FEVER, EBOLA; HOSPITAL; PROCEDURES; STANDARDS;

CLINICAL LABORATORY TECHNIQUES; DELIVERY OF HEALTH CARE; HEMORRHAGIC FEVER, EBOLA; HOSPITALS; HUMANS; SPAIN;

EID: 84946854835     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0105     Document Type: Review

References (40)

1. ECDC. Factsheet for health professionals. European Centre for Disease Prevention and Control. Available from: http://ecdc. europa.eu/en/healthtopics/ebola-marburg-fevers/factsheetfor-health-professionals/Pages/factsheet-health-professionals. aspx. Accessed 25 January, 2015.
2. Evaluación del riesgo para España de la epidemia de fiebre hemorrágica por el virus de Ebola en Africa Occidental, Ministry of Health, Social Services and Equality Directorate General of Public Health, Quality and Innovation. Available from: http://www.msssi.gob.es/profesionales/saludPublica/ccayes/alertasActual/ebola/docs/E-Riesgo-para-Espana-Fiebre-hemorragica-Ebola-Diciembre.2014.pdf. Accessed 25 January, 2015.
3. WHO: Ebola virus disease. World Health Organisation. Available from: http://who.int/mediacentre/factsheets/fs103/en/. Accessed 25 January, 2015.
4. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: A study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies à Kikwit. J Infect Dis 1999;179:S87-91.
5. Jaax NK, Davis KJ, Geisbert TJ, Vogel P, Jaax GP, Topper M, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996;120:140-55.
6. Twenhafel NA, Mattix ME, Johnson JC, Robinson CG, Pratt WD, Cashman KA, et al. Pathology of experimental aerosol Zaire Ebola virus infection in rhesus macaques. Vet Pathol 2013;50:514-29.
7. Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamiliar spread. Bull WHO 1983;61:997-1003.
8. CDC. Centers for Disease Control and Prevention. Outbreaks chronology: Ebola hemorrhagic fever. Atlanta, GA: Centers for Disease Control and Prevention, 2014. Available from: www.cdc. gov/vhf/ebola/resources/outbreak-table.html. Accessed 25 January, 2015.
9. WHO. Global Alert and Response (GAR)-Ebola virus disease. Available from: http://www.who.int/csr/disease/ebola/en/. Accessed 25 January, 2015.
10. CDC. Ebola hemorrhagic fever. Atlanta, GA: Centers for Disease Control and Prevention, 2014. Available from: http://www.cdc. gov/vhf/ebola/symptoms/index.html. Accessed 25 January, 2015.
11. WHO. Clinical management of patients with viral haemorrhagic fever. A pocket guide for the front-line health worker; April 2014. Available from: http://www.who.int/csr/resources/publications/clinical-management-patients/en/. Accessed 25 January, 2015.
12. Oottamasathien D, Jones A, Boisen M, Kulakosky P, Wilson R, Branco L. Development of a point-of-care diagnostic for Ebola and Sudan virus detection. American Association for Clinical Chemistry Congress (AACC); Chicago, July 2014.
13. Mapp Biopharmaceutical, Inc., San Diego, CA. Available from: http://www.mappbio.com/. Accessed 25 January, 2015.
14. ECDC. Treatment and vaccine development. European Centre for Disease Prevention and Control. Available from: http://www.ecdc.europa.eu/en/healthtopics/ebola-marburg-fevers/Pages/treatment-vaccines.aspx. Accessed 25 January, 2015.
15. Actualización Epidemiológica. Brote de fiebre hemorrágica por el virus de Ebola en Africa Occidental.: 19 de diciembre de 2014. Ministry of Health, Social Services and Equality. Directorate General of Public Health, Quality and Innovation. Available from: http://www.msssi.gob.es/profesionales/saludPublica/ccayes/alertasActual/ebola/documentos/Actualizacion-23BIS-(19.12.2014)-EPI-EVE-Africa-2014.pdf. Accessed 25 January, 2015.
16. WHO. Ebola situation report, 7 January 2015. Available from: http://apps.who.int/iris/bitstream/10665/147112/1/roadmapsitrep-7Jan2015-eng.pdf?ua=1&ua=1. Accessed 25 January, 2015.
17. OSHA's bloodborne pathogens standard. Occupational Safety and Health Administration. Available from: https://www.osha.gov/pls/publications/publication. searchResults?pSearch=OSHA%20bloodborne%20pathogens% 20standard. Accessed 25 January, 2015.
18. WHO. Ebola response roadmap situation report 17 December 2014. Available from: http://apps.who.int/iris/bitstream/10665/145679/1/roadmapsitrep-17Dec2014-eng. pdf?ua=1. Accessed 25 January, 2015.
19. Fauci AS. Ebola-underscoring the global disparities in health care resources. N Engl J Med 2014;371:1084-6.
20. WHO. Ebola virus disease in West Africa-The first 9 months of the epidemic and forward projections. WHO Ebola Response Team. N Engl J Med 2014;371:1481-95.
21. WHO. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa. Available from: http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/es/. Accessed 25 January, 2015.
22. ECDC. Rapid risk assessment outbreak of Ebola virus disease in West Africa, eighth update, 18 November 2014. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Risk-assessment-Ebola-haemorrhagic-fever-Zaire-ebolavirus-Sierra-Leone-Liberia-Guinea-Spain-United-States.pdf. Accessed 25 January, 2015.
23. CDC. Centers for Disease Control and Prevention. Infection prevention and control recommendations for hospitalized patients with known or suspected Ebola hemorrhagic fever in U.S. hospitals. Atlanta, GA: Centers for Disease Control and Prevention; 2014. Available from: www.cdc.gov/vhf/ebola/hcp/infectionprevention-and-control-recommendations.html. Accessed 25 January, 2015.
24. WHO. Statement on the meeting of the International Health Regulations Emergency Committee regarding the 2014 Ebola outbreak in West Africa. World Health Organization. Available from: http://who.int/mediacentre/news/statements/2014/ebola-20140808/en/. Accessed 25 January, 2015.
25. Summary guidance for acute trust staff: frequently asked questions (FAQs) on laboratory testing of samples from patients with possible Ebola virus disease. Available from: https://www.gov. uk/government/uploads/system/uploads/attachment-data/file/346275/Summary-guidance-for-acute-trust-staff-Labs-15-08-2014.pdf. Accessed 25 January, 2015.
26. Frieden T. The health care blog. CDC laboratory guidance on Ebola. Available from: http://thehealthcareblog.com/blog/2014/08/20/cdc-laboratory-guidance-on-ebola/. Accessed 25 January, 2015.
27. Malone B. Confronting Ebola in the U.S., labs race to plan with evolving guidance and missing details. Clin Lab News, 1 December, 2014.
28. Management of Hazard Group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence. Advisory Committee on Dangerous Pathogens. Health and Safety Executive (HSE). UK; November 2014. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/377143/VHF-guidance-document-updated-19112014.pdf. Accessed 25 January, 2015.
29. WHO. Infection prevention and control guidance for care of patients in health-care settings, with focus on Ebola.http://www.who.int/csr/resources/publications/ebola/filovirus-infection-control/en/.
30. Available from: http://apps.who.int/iris/bitstream/10665/130596/1/WHO-HIS-SDS-2014.4-eng. pdf?ua=1&ua=1&ua=1. Accessed 25 January, 2015.
31. Centers for Disease Control and Prevention. Interim guidance for specimen collection, transport, testing, and submission for persons under investigation for Ebola virus disease in the United States. Available from: http://www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collection-submission-patientssuspected-infection-ebola.html. Accessed 25 January, 2015.
32. Centres for Disease Control and Prevention. How U.S. clinical laboratories can safely manage specimens from persons under investigation for Ebola virus disease. Available from: http://www.cdc.gov/vhf/ebola/hcp/safe-specimen-management.html. Accessed 25 January, 2015.
33. Lippi LE, Mattiuzzi C, Plebani M. Laboratory preparedness to face infectious outbreaks. Ebola and beyond. Clin Chem Lab Med 2014;52:1681-4.
34. Hill CE, Burd EM, Kraft CS, Ryan EL, Duncan A, Winkler AM, et al. Laboratory test support for Ebola patients within a high-containment facility. Lab Med 2014;45:e109-11.
35. Klompas M, Diekema DJ, Fishman NO, Yokoe DS. Ebola fever: reconciling Ebola planning with Ebola risk in U.S. hospitals. Ann Intern Med 2014;161:751-2.
36. CDC. Guidance on personal protective equipment to be used by healthcare workers during management of patients with Ebola virus disease in U.S. hospitals, including procedures for putting on (donning) and removing (doffing). Available from: http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html. Accessed 25 January, 2015.
37. Mitchell SW, McCormick JB. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microb 1984;20:486-9.
38. Bhagat CI, Lewer M, Prins A, Beilby JP. Effects of heating plasma at 56 degrees C for 30 min and at 60 degrees C for 60 min on routine biochemistry analytes. Ann Clin Biochem 2000;37:802-4.
39. WHO. Organización Mundial de la Salud, Oficina regional para las Américas, Organización Panamericana de la Salud. Procedimientos generales para inactivación de muestras potencialmente infecciosas con el virus ebola y otros agentes virales altamente patógenos. Available from: http://www. paho.org/hq/index.php?option=com-docman&task=doc-vie w&Itemid=270&gid=27984&lang=es. Accessed 25 January, 2015.
40. WHO. Laboratory guidance for the diagnosis of Ebola virus disease interim recommendations. Available from: http://www. who.int/entity/csr/resources/publications/ebola/laboratoryguidance/en/index.html). Accessed 25 January, 2015.